Award-winning medtech firm, Glyconics© has secured £1.5million in an Enterprise Investment Scheme (EIS) funding round ahead of a series A round next year. The innovative diagnostics startup, with offices in Cambridge, Norwich and Basingstoke, raised well over the intended £850k in a raise led by investment platform Wealth Club and existing investors, Deepbridge Capital and Boundary Capital. Demand from Wealth Club private investors and angel investors pushed the total amount further to £1.5 million.

Charco Neurotech, a medical technology company that develops solutions for people with Parkinson’s, has raised $10m seed investment round, co-led by technology investors Amadeus Capital Partners and Parkwalk Advisors, and joined by University of Tokyo Edge Capital Partners (UTEC), MINT Venture Partners, and existing investors, including Crista Galli Ventures. The financing is the largest European seed round in 2021 and the sixth largest globally for healthtech devices, according to Pitchbook.

Charco is a multi-award winning, Imperial College spinout. Its first therapeutic device, CUE1, provides life-changing neuromodulation therapy.

Gentronix, the UK-based contract research organisation (CRO) that is a leader in the field of genetic toxicology, has raised £700,000 in a funding round led by existing investor Mercia to support its continued growth.

Kernel Capital portfolio company B-Secur Ltd, a Belfast-based health tech company, has completed a total raise of £8.8 million (USD $12 million) of investment in 2021, with the latest round led by US-based First Capital Ventures and The Bank of Ireland Kernel Capital Growth Fund NI increasing its investment level to £2.2M with other existing investors also participating.

Chepstow based health tech firm Forth is set to capitalise on the growth in the female science and technology market as it has secured £1.6m funding to support the launch of its ground-breaking female health product. Leading the team at Forth is CEO and Co-Founder Sarah Bolt. She said: “Today, more and more people are realising that understanding and measuring your body’s biochemistry is key for a long and healthy life. For women in particular, gaining unique insight into how their hormone levels fluctuate throughout their unique cycle can give women the support they have been lacking and help to close the gender health gap”. 

Closed Loop Medicine, the global leader in the development of single prescription drug plus digital therapy (DTx) combination products to enable precision dosing, has closed a £13 million financing. 

Dr Louise Rix, a former VC at Forward Partners, is stepping into the start-up world and taking up a new role as Chief Medical Officer at femtech start-up Béa Fertility. 

Maven Capital Partners, one of the UKs most active investors in growing businesses,  has invested £3.25 million in London-based RwHealth 

Sphere Fluidics, has closed a $40 million (circa £30 million) investment round. 

Pharmacierge, the healthtech company that offers same-day prescription medicine delivery in London and next day delivery throughout the UK, has raised £1.25m from a number of leading clinicians and angel investors.  Investors include Alex Chesterman OBE, founder of Cazoo and Zoopla and Simon Franks, who co-founded Lovefilm. In a show of confidence from the medical profession, many practitioner users have also invested in the round, 

Imophoron, a developer of a novel, next generation rapid-response vaccine platform, ADDomer(TM), to combat present and future infectious diseases, has secured £4 million in an oversubscribed fundraising round. 

Entia, a medical technology business, which recently announced a commercial partnership with Pfizer UK, raised $12 million earlier in the year in a funding round co-led by UK growth capital investor, BGF and growth fund manager, Parkwalk, with participation from existing seed investor Sussex Place Ventures.